Takeover Possibility
Can Saggy Fitbit Regain Its Shape? This Value Investor Hopes So
Shares of the maker of health and fitness devices are near their all-time low, but buying now could pay off down the road.
AbbVie Joins Giant Acquisition Trend in Big Pharma With Allergan Deal
The proposed, $63 billion transaction is the latest deal in an industry where it can be cheaper to buy the science of another company than develop products.
2 Midcaps to Watch Should Pfizer-Array Deal Spark M&A Fever in Biotech Land
These two firms have successful drugs and could make nice additions for larger companies.
2 Small Biotechs With Sagging Shares but Promising Prospects
The stocks of these two developmental concerns have slid recently, but there are reasons to believe they will improve.
Why an Etsy, Pinterest Partnership Makes Sense
If Pinterest is pinning its hopes of profitability on e-commerce, Etsy would be an excellent choice.
It's Tough to Milk Any Profits From Dean Foods
Rumors of a potential company sale gave its shares a lift on Monday, but the stock remains extremely depressed as the dairy producer wallows in red ink.
Who Might the Oil Majors Acquire Next After Chevron's Anadarko Deal?
A rundown of several oil companies that could soon be on the block.
Wynn Resorts Craps Out on Crown Resorts, but Will It Return to the Table?
Wynn aborted talks to acquire Australia's largest casino operator when word of the negotiations leaked, but observers think a deal still may happen.
Jim Cramer: Nvidia's Mellanox Deal, and Apple Upgrade, Have Lifted the Semis
It signals the glut in chips may be done with, which is good news for most of the semiconductor names.
Roche Deal for Spark Therapeutics Shows Biotech M&A Spark Hasn't Died
Acquisition deals for biotech companies at the start of 2019 are giving the sector a nice boost; here are other names that could be merger candidates.